Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP0991919
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Inhibition of pro-inflammatory cytokine secretion- A new route to therapeutics of chronic inflammatory disease. Chronic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease, affect millions of people leading to considerable suffering, economic loss and premature death. Anti-TNF treatments have recently shown success in the treatment of rheumatoid arthritis, inflammatory bowel disease and other conditions, however, a substantial number of patients (~50%) do not respond to the current TNF treatments. Improved anti-TNF strategies would provide enhanced health outcomes and welcome relief to many Australians. In addition, the economic benefit of the TNF market is very substantial. Therefore the potential impact of this research is very high both for health care and economical potential.Funded Activity Details
Start Date: 05-2010
End Date: 05-2013
Funding Scheme: Linkage Projects
Funding Amount: $336,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Genetic Technologies: Transformation, Site-Directed Mutagenesis, Etc. | Autoimmunity | Immunology | Protein Targeting And Signal Transduction |
